Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods
Open Access
- 1 February 2005
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (2), 925-927
- https://doi.org/10.1128/jcm.43.2.925-927.2005
Abstract
An eight-laboratory study addressed the urgent need for quality control (QC) ranges for susceptibility determination when testing colistin (polymyxin E) and polymyxin B, two polycationic peptide antimicrobial agents, against multidrug-resistant gram-negative bacilli. For Escherichia coli ATCC 25922l, the QC ranges were as follows: for colistin, 0.25 to 1 μg/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 μg/ml (13 to 19 mm). For Pseudomonas aeruginosa ATCC 27853, the QC ranges were as follows: for colistin, 0.25 to 2 μg/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 μg/ml (14 to 18 mm). More than 97% of all reported QC results were within these proposed ranges.Keywords
This publication has 9 references indexed in Scilit:
- Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 2003
- Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2003
- Colistin: An Antimicrobial for the 21st Century?Clinical Infectious Diseases, 2002
- Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control GuidelinesJournal of Clinical Microbiology, 2001
- Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative BacteriaAnnals of Pharmacotherapy, 1999
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniquesAntimicrobial Agents and Chemotherapy, 1992
- SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINSBritish Journal of Pharmacology and Chemotherapy, 1964
- Microbiological and pharmacological studies of colistin sulfate and sodium colistinmethanesulfonate.1959